Market Research Logo

Glucose Monitoring Global Market - Forecast to 2023

Glucose Monitoring Global Market - Forecast to 2023

Glucose Monitoring consist of products that are essential for patients suffering diabetes. With the projected rise in aged population and awareness about such conditions, the market is focused on growing with newer technology and improved products. According to IQ4I analysis, the Glucose Monitoring global market is expected to grow at single digit CAGR to reach $11,248.5 million by 2023. Factors driving the Glucose Monitoring market are global rise in the prevalence and incidence of diabetes, continuous technological advancement, increasing demand for less invasive products, and increase in R&D investments are driving the market growth. Increase in obesity population due to lifestyle changes, increase in urbanization, untapped markets like Middle East, Africa shows that glucose monitoring market has vast opportunities in the coming years. Frequent product recalls i.e. glucose testing strips due to manufacturing defects or supply of expired test strips and less product differentiation among the self blood glucose monitors are the factors that are restraining the market growth. The limited reimbursement facilities and alternative treatments that include cell based assays, biomarkers identification and artificial pancreas and high cost associated with Continuous Glucose Monitoring (CGM) are threats for the market growth.

Glucose Monitoring global market is classified based on products, sample type, end-users and geography. The products segment is divided into three segments i.e., Invasive, Non-Invasive and lab based glucose monitoring products. The Invasive glucose monitoring products segment accounted the largest share in 2016 due to technological advancements, easy use, patient friendly etc. Invasive products are classified into Self glucose monitoring and continuous glucose products. The self glucose monitoring segment accounted the largest share in 2016 due to development of minimally invasive products. The Self glucose monitoring products are further classified into blood glucose monitors, blood glucose test strips, lancets and others. The blood glucose testing strips segment accounted for the largest share in 2016 due development of no coding strips. The continuous glucose monitoring market includes sensors/receiver and transmitter. The continuous glucose market includes products sensors/receiver and transmitter. Continuous glucose segment is fastest growing segment and is projected to grow at a strong CAGR of XX% from 2016 to 2023.

Based on sample type the market is segmented into blood, urine and others. The blood segment accounted the largest share in 2016 and is projected to grow at a CAGR of 0.3% from 2016 to 2023 due to the accuracy of results. Other source based glucose monitoring segment is fastest growing segment and is projected to grow at a strong CAGR of XX% from 2016 to 2023 due to increases R & D investment, many product are CE approved and expected launch very soon in market.

Based on end users the market is segmented into hospitals, private clinics, home care and ambulatory settings. Among end-users, home care segment accounted for the largest share in 2016 and is projected to grow at a strong CAGR of X% from 2016 to 2023 due to availability of self blood monitor over the counter and ease in operating these monitors and thereby reduces dependence on any clinics for glucose check.

Based on geography the market is segmented into North America (U.S. and Others), Europe (Germany, France, U.K. and Others), Asia-Pacific (Japan, China, India and Others) and Rest of the World (Brazil, Middle East & others and Rest of Latin America). North America accounts for the highest market share of XX% followed by Europe. The steep rise in aging population, advancement in technology, awareness of people about treatment options and favorable government policies are driving factors of glucose monitoring market. However, Asian countries especially India and China are the fastest growing regions with its growing demand for glucose monitoring products.

Major players in Glucose monitoring market include Roche (Switzerland), Dexcom (U.S.), B. Braun Melsungen AG (Germany), Medtronic, Inc. (Ireland), Johnson & Johnson (U.S.), Abbott Laboratories (U.S.), AgaMatrix (U.S.), Arkray (Japan), Ascensia (Switzerland), Trividia Health, Inc (U.S.) etc.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

North America

  • U.S.
  • Others
Europe
  • Germany
  • U.K.
  • France
  • Others
Asia-Pacific
  • Japan
  • China
  • India
  • Others
Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle-East (Middle East & Others)


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Global rise in the prevalence and incidence of diabetes
3.3.1.2 Continuous technological advancements in glucose monitoring devices
3.3.1.3 Increasing demand for less invasive devices or point of care
3.3.1.4 Increasing R & D investments
3.3.2 RESTRAINS AND THREATS
3.3.2.1 Availability of alternative treatment
3.3.2.2 High cost associated with the products
3.3.2.3 Inadequate reimbursement
3.3.2.4 Product recalls
3.3.2.5 Strict regulation of glucose monitoring devices by regulatory
organizations like FDA and others.
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 CHINA
3.4.4 INDIA
3.5 REIMBURSEMENT SCENARIO
3.6 PATENT ANALYSIS
3.7 TECHNOLOGY ADVANCEMENTS
3.7.1 NO-STRIP TECHNOLOGY
3.7.2 NO-CODING TECHNOLOGY
3.7.3 SOURCE ADVANCEMENTS
3.7.4 WEARABLE OR WIRELESS TECHNOLOGY
3.8 UPCOMING TECHNOLOGY AND PRODUCT LAUNCH
3.9 FUNDING SCENARIO
3.10 GLUCOSE MONITORING - DEALS
3.11 CLINICAL TRIAL DATA
3.12 PORTER’S FIVE FORCE ANALYSIS
3.12.1 THREAT OF NEW ENTRANTS
3.12.2 THREAT OF SUBSTITUTES
3.12.3 BARGAINING POWER OF SUPPLIERS
3.12.4 BARGAINING POWER OF BUYERS
3.12.5 RIVALRY AMONG EXISTING COMPETITORS
3.13 SUPPLY CHAIN ANALYSIS
3.14 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.14.1 GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS
3.14.2 SELF BLOOD GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS
3.14.3 CONTINUOUS GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS
3.14.4 LAB-BASED GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS
4 GLUCOSE MONITORING GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 INVASIVE GLUCOSE MONITORING
4.3 SELF GLUCOSE MONITORING
4.3.1 BLOOD GLUCOSE METER
4.3.2 BLOOD GLUCOSE TESTING STRIPS
4.3.3 LANCETS
4.3.4 OTHERS
4.4 CONTINUOS GLUCOSE MONITORING
4.4.1 GLUCOSE SENSORS
4.4.2 TRANSMITTERS AND RECEIVERS
4.5 NON-INVASIVE GLUCOSE MONITORING
4.6 LAB BASED GLUCOSE MONITORING
5 GLUCOSE MONITORING GLOBAL MARKET, BY SAMPLE SOURCE
5.1 INTRODUCTION
5.2 BLOOD BASED GLUCOSE MONITORING
5.3 URINE BASED GLUCOSE MONITORING
5.4 OTHER SOURCES BASED GLUCOSE MONITORING
6 GLUCOSE MONITORING GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 HOME CARE
6.4 PRIVATE CLINICS
6.5 AMBULATORY SETTINGS
7 REGIONAL ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 OTHERS
7.3 EUROPE
7.3.1 GERMANY
7.3.2 U.K.
7.3.3 FRANCE
7.3.4 OTHERS
7.4 ASIA - PACIFIC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 OTHERS
7.5 REST OF THE WORLD
7.5.1 BRAZIL
7.5.2 MIDDLE EAST & OTHERS
7.5.3 REST OF LATIN AMERICA
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 APPROVALS
8.3 NEW PRODUCT LAUNCHES
8.4 AGREEMENTS, ACQUISITIONS & COLLABORATION
8.5 OTHER DEVELOPMENTS
9 MAJOR COMPANIES
9.1 ABBOTT LABORATORIES, INC
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 AGAMATRIX, INC.
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 ARKRAY, INC.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 ASCENSIA DIABETES CARE HOLDINGS AG.
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 B.BRAUN MELSUNGEN AG
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 BIO-RAD LABORATORIES
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 DEXCOM INC.
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 JOHNSON & JOHNSON
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 MEDTRONIC, PLC
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 TRIVIDIA HEALTH, INC.
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 ROCHE HOLDINGS AG
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
TABLE 2 GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 3 INVASIVE GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 4 INVASIVE GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 5 SELF GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 6 SELF GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 7 BLOOD GLUCOSE METER GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 8 BLOOD GLUCOSE TESTING STRIPS GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 9 LANCETS GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 10 OTHERS GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 11 CONTINUOUS GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY PRODUCTS (2015-2023) ($MN)
TABLE 12 CONTINUOUS GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY REGION (2015 - 2023) ($MN)
TABLE 13 GLUCOSE SENSORS GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 14 TRANSMITTER AND RECEIVERS GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 15 NON-INVASIVE GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 16 LAB BASED GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 17 GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY SAMPLE SOURCE (2015-2023) ($MN)
TABLE 18 BLOOD BASED GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 19 URINE BASED GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 20 OTHER SOURCE BASED GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 21 GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY END-USER (2015-2023) ($MN)
TABLE 22 GLUCOSE MONITORING HOSPITAL GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 23 GLUCOSE MONITORING HOME CARE GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 24 GLUCOSE MONITORING PRIVATE CLINICS GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 25 GLUCOSE MONITORING AMBULATORY SETTINGS GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 26 GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN)
TABLE 27 NORTH AMERICA GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 28 NORTH AMERICA INVASIVE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 29 NORTH AMERICA SELF BLOOD GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 30 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 31 NORTH AMERICA GLUCOSE MONITORING MARKET REVENUE, BY SAMPLE SOURCE (2015-2023) ($MN)
TABLE 32 NORTH AMERICA GLUCOSE MONITORING MARKET REVENUE, BY END-USER (2015-2023) ($MN)
TABLE 33 NORTH AMERICA GLUCOSE MONITORING MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
TABLE 34 EUROPE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 35 EUROPE INVASIVE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 36 EUROPE SELF BLOOD GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 37 EUROPE CONTINUOUS GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 38 EUROPE GLUCOSE MONITORING MARKET REVENUE, BY SAMPLE SOURCE (2015-2023) ($MN)
TABLE 39 EUROPE GLUCOSE MONITORING MARKET REVENUE, BY END-USER (2015-2023) ($MN)
TABLE 40 EUROPE GLUCOSE MONITORING MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
TABLE 41 ASIA-PACIFIC GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 42 ASIA-PACIFIC INVASIVE GLUCOSE MONITORING MARKET REVENUE,BY PRODUCTS (2015-2023) ($MN)
TABLE 43 ASIA-PACIFIC SELF BLOOD GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 44 ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 45 ASIA-PACIFIC GLUCOSE MONITORING MARKET REVENUE, BY SAMPLE SOURCE (2015-2023) ($MN)
TABLE 46 ASIA-PACIFIC GLUCOSE MONITORING MARKET REVENUE, BY END-USER (2015-2023) ($MN)
TABLE 47 ASIA-PACIFIC GLUCOSE MONITORING MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
TABLE 48 ROW GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 49 ROW INVASIVE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 50 ROW SELF BLOOD GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015- 2023) ($MN)
TABLE 51 ROW CONTINUOUS GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
TABLE 52 ROW GLUCOSE MONITORING MARKET REVENUE, BY SAMPLE SOURCE (2015-2023) ($MN)
TABLE 53 ROW GLUCOSE MONITORING MARKET REVENUE, BY END-USER (2015-2023) ($MN)
TABLE 54 ROW GLUCOSE MONITORING MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
TABLE 55 APPROVALS (2016-2017)
TABLE 56 NEW PRODUCT LAUNCHES (2016-2017)
TABLE 57 AGREEMENTS, ACQUISITIONS & COLLABORATION (2016-2017)
TABLE 58 OTHERS (2016-2017)
TABLE 59 ABBOTT LABORATORIES, INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 60 ABBOTT LABORATORIES, INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 61 ABBOTT LABORATORIES, INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 62 B BRAUN MELSUNGEN: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
TABLE 63 B BRAUN MELSUNGEN: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
TABLE 64 B BRAUN MELSUNGEN: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
TABLE 65 BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
TABLE 66 BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 67 BIO-RAD LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 68 DEXCOM INC: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
TABLE 69 DEXCOM INC: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
TABLE 70 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 71 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 72 JOHNSON & JOHNSON: TOTAL REVENUE, BY MEDICAL DEVICES SEGMENTS, (2014-2016) ($MN)
TABLE 73 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 74 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 75 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 76 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 77 ROCHE HOLDINGS AG: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 78 ROCHE HOLDINGS AG: TOTAL REVENUE BY SEGMENTS, (2014-2016) ($MN)
TABLE 79 ROCHE HOLDINGS AG: DIAGNOSTICS REVENUE, BY TYPES, (2014-2016) ($MN)
TABLE 80 ROCHE HOLDINGS AG: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
LIST OF FIGURES
FIGURE 1 GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY REGION (2015-2023) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: GLUCOSE MONITORING GLOBAL MARKET
FIGURE 3 GLUCOSE MONITORING GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 GLUCOSE MONITORING GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 GLUCOSE MONITORING GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 GLUCOSE MONITORING GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 GLUCOSE MONITORING GLOBAL MARKET: PATENT FILING,
BY MAJOR PLAYERS (2012-2017)
FIGURE 9 GLUCOSE MONITORING MARKET: PORTER’S ANALYSIS
FIGURE 10 GLUCOSE MONITORING GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 11 GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS,
BY KEY PLAYERS, 2016
FIGURE 12 SELF BLOOD GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
FIGURE 13 CONTINUIUOS GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
FIGURE 14 LAB BASED GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS,
BY KEY PLAYERS, 2016
FIGURE 15 GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY PRODUCTS (2016 V/S 2023) ($MN)
FIGURE 16 GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY PRODUCTS (2016) ($MN)
FIGURE 17 INVASIVE GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY PRODUCTS (2015-2023) ($MN)
FIGURE 18 INVASIVE GLUCOSE MONITORING GLOBAL MARKET SHARE,
BY REGION (2016 V/S 2023) (%)
FIGURE 19 SELF GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY PRODUCTS (2016 V/S 2023) ($MN)
FIGURE 20 SELF GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY REGION (2016 V/S 2023) ($MN)
FIGURE 21 BLOOD GLUCOSE METER GLOBAL MARKET REVENUE,
BY REGION (2016 V/S 2023) ($MN)
FIGURE 22 BLOOD GLUCOSE TESTING STRIPS GLOBAL MARKET REVENUE,
BY REGION (2016 V/S 2023) ($MN)
FIGURE 23 LANCETS GLOBAL MARKET REVENUE, BY REGION (2016 V/S 2023) ($MN)
FIGURE 24 OTHERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
FIGURE 25 CONTINUOUS GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY PRODUCTS (2015-2023) ($MN)
FIGURE 26 CONTINUOUS GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY REGION (2015-2023) ($MN)
FIGURE 27 GLUCOSE SENSORS GLOBAL MARKET REVENUE,
BY REGION (2016 V/S 2023) ($MN)
FIGURE 28 TRANSMITTER AND RECEIVER GLOBAL MARKET REVENUE,
BY REGION (2016 V/S 2023) ($MN)
FIGURE 29 NON-INVASIVE DEVICE RESEARCH FOCUS BASED ON SOURCE
FIGURE 30 NON-INVASIVE GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY REGION (2016 V/S 2023) ($MN)
FIGURE 31 LAB BASED GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY REGION (2015-2023) ($MN)
FIGURE 32 GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 33 BLOOD BASED GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY REGION (2016 V/S 2023) ($MN)
FIGURE 34 URINE BASED GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY REGION (2016 V/S 2023) ($MN)
FIGURE 35 OTHER SOURCES BASED GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION (2016 V/S 2023) ($MN)
FIGURE 36 GLUCOSE MONITORING GLOBAL MARKET SHARE,
BY END -USER (2016) (%)
FIGURE 37 GLUCOSE MONITORING HOSPITAL GLOBAL MARKET REVENUE,
BY END -USER (2016 V/S 2023) ($MN)
FIGURE 38 GLUCOSE MONITORING HOME CARE GLOBAL MARKET REVENUE,
BY END -USER (2016 V/S 2023) ($MN)
FIGURE 39 GLUCOSE MONITORING PRIVATE CLINICS GLOBAL MARKET REVENUE,
BY END -USER (2016 V/S 2023) ($MN)
FIGURE 40 GLUCOSE MONITORING AMBULATORY SETTINGS GLOBAL MARKET REVENUE, BY END -USER (2016 V/S 2023) ($MN)
FIGURE 41 GLUCOSE MONITORING GLOBAL MARKET REVENUE,
BY REGION (2015 - 2023) ($MN)
FIGURE 42 NORTH AMERICA GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2016) ($MN)
FIGURE 43 NORTH AMERICA SELF BLOOD GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
FIGURE 44 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
FIGURE 45 NORTH AMERICA GLUCOSE MONITORING MARKET REVENUE,
BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 46 NORTH AMERICA GLUCOSE MONITORING MARKET SHARE,
BY END-USER (2016) (%)
FIGURE 47 NORTH AMERICA GLUCOSE MONITORING MARKET REVENUE,
BY COUNTRY (2015-2023) ($MN)
FIGURE 48 U.S. GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
(2016 VS 2023) ($MN), BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 49 U.S. GLUCOSE MONITORING MARKET SHARE, BY END-USER (2016) (%)
FIGURE 50 OTHERS GLUCOSE MONITORING MARKET REVENUE, BY PRODUCT,
(2016 VS 2023) ($MN), BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 51 OTHERS GLUCOSE MONITORING MARKET SHARE,
BY END-USER (2016) (%)
FIGURE 52 EUROPE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS
(2016) ($MN)
FIGURE 53 EUROPE SELF BLOOD GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2016 V/S 2023) ($MN)
FIGURE 54 EUROPE CONTINUOUS GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2015-2023) ($MN)
FIGURE 55 EUROPE GLUCOSE MONITORING MARKET REVENUE, BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 56 EUROPE GLUCOSE MONITORING MARKET SHARE, BY END-USER (2016) (%)
FIGURE 57 EUROPE GLUCOSE MONITORING MARKET REVENUE, BY COUNTRY
(2015-2023) ($MN)
FIGURE 58 GERMANY GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
(2016 VS 2023) ($MN), BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 59 GERMANY GLUCOSE MONITORING MARKET SHARE,
BY END-USER (2016) (%)
FIGURE 60 U.K. GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
(2016 VS 2023) ($MN), BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 61 U.K. GLUCOSE MONITORING MARKET SHARE, BY END-USER (2016) (%)
FIGURE 62 FRANCE GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
(2016 VS 2023) ($MN), BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 63 FRANCE GLUCOSE MONITORING MARKET SHARE,
BY END-USER (2016) (%)
FIGURE 64 OTHER GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
(2016 VS 2023) ($MN), BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 65 OTHERS GLUCOSE MONITORING MARKET SHARE,
BY END-USER (2016) (%)
FIGURE 66 ASIA-PACIFIC GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2016) ($MN)
FIGURE 67 ASIA-PACIFIC SELF BLOOD GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2016 V/S 2023) ($MN)
FIGURE 68 ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2015-2023) ($MN)
FIGURE 69 ASIA-PACIFIC GLUCOSE MONITORING MARKET REVENUE,
BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 70 ASIA-PACIFIC GLUCOSE MONITORING MARKET SHARE,
BY END-USER (2016) (%)
FIGURE 71 ASIA-PACIFIC GLUCOSE MONITORING MARKET REVENUE,
BY COUNTRY (2015-2023) ($MN)
FIGURE 72 JAPAN GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
(2016 VS 2023) ($MN), BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 73 JAPAN GLUCOSE MONITORING MARKET SHARE, BY END-USER (2016) (%)
FIGURE 74 CHINA GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
(2016 VS 2023) ($MN), BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 75 CHINA GLUCOSE MONITORING MARKET SHARE, BY END-USER (2016) (%)
FIGURE 76 INDIA GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
(2016 VS 2023) ($MN), BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 77 INDIA GLUCOSE MONITORING MARKET SHARE, BY END-USER (2016) (%)
FIGURE 78 OTHER GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
(2016 VS 2023) ($MN), BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 79 OTHERS GLUCOSE MONITORING MARKET SHARE, BY END-USER
(2016) (%)
FIGURE 80 ROW GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS
(2016) ($MN)
FIGURE 81 ROW SELF BLOOD GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2016 V/S 2023) ($MN)
FIGURE 82 ROW CONTINUOUS GLUCOSE MONITORING MARKET REVENUE,
BY PRODUCTS (2015-2023) ($MN)
FIGURE 83 ROW GLUCOSE MONITORING MARKET REVENUE, BY SAMPLE SOURCE
(2016 V/S 2023) ($MN)
FIGURE 84 ROW GLUCOSE MONITORING MARKET SHARE, BY END-USER (2016) (%)
FIGURE 85 ROW GLUCOSE MONITORING MARKET REVENUE, BY COUNTRY
(2015-2023) ($MN)
FIGURE 86 BRAZIL GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS,
(2016 VS 2023) ($MN), BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 87 BRAZIL GLUCOSE MONITORING MARKET SHARE, BY END-USER (2016) (%)
FIGURE 88 MIDDLE EAST GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS, (2016 VS 2023) ($MN), BY SAMPLE SOURCE (2016 V/S 2023) ($MN)
FIGURE 89 MIDDLE EAST GLUCOSE MONITORING MARKET SHARE,
BY END-USER (2016) (%)
FIGURE 90 REST OF LATIN AMERICA GLUCOSE MONITORING MARKET REVENUE, BY PRODUCTS, (2016 VS 2023) ($MN), BY SAMPLE SOURCE (20162 V/S 2023) ($MN)
FIGURE 91 REST OF LATIN AMERICA GLUCOSE MONITORING MARKET SHARE,
BY END-USER (2016) (%)
FIGURE 92 KEY GROWTH STRATEGIES (2016 – 2017)
FIGURE 93 APPROVALS BY MAJOR COMPANIES (2016-2017)
FIGURE 94 NEW PRODUCT LAUNCH BY MAJOR COMPANIES (2016-2017)
FIGURE 95 AGREEMENTS, ACQUISITIONS & COLLABORATION BY MAJOR COMPANIES (2016-2017)
FIGURE 96 OTHER DEVELOPMENTS (2016-2017)
FIGURE 97 SWOT: ABBOTT LABORATORIES
FIGURE 98 SWOT: AGAMATRIX, INC
FIGURE 99 SWOT: ARKRAY, INC
FIGURE 100 SWOT: ASCENSIA DIABETES CARE
FIGURE 101 SWOT: B BRAUN MELSUNGEN
FIGURE 102 SWOT: BIO-RAD LABORATORIES
FIGURE 103 SWOT: DEXCOM INC.
FIGURE 104 SWOT: JOHNSON & JOHNSON
FIGURE 105 SWOT: MEDTRONIC, PLC
FIGURE 106 SWOT: TRIVIDIA HEALTH, INC
FIGURE 107 SWOT: ROCHE HOLDINGS AG

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report